These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 37715427)
1. The discovery of the natural compound Boeravinone-C as a potential antiobesity drug candidate targeting pancreatic lipase using chemo-informatics-based approaches. Unnisa A; Anwar S; Ananda K C; Khalifa NE; Khojali WMA; Osman ME; M Younes K; S Abouzied A; Jandrajupalli SB; Chandolu S Cell Mol Biol (Noisy-le-grand); 2023 Jul; 69(7):57-65. PubMed ID: 37715427 [TBL] [Abstract][Full Text] [Related]
2. Boerhaavia diffusa inhibits key enzymes linked to type 2 diabetes in vitro and in silico; and modulates abdominal glucose absorption and muscle glucose uptake ex vivo. Oyebode OA; Erukainure OL; Chukwuma CI; Ibeji CU; Koorbanally NA; Islam S Biomed Pharmacother; 2018 Oct; 106():1116-1125. PubMed ID: 30119178 [TBL] [Abstract][Full Text] [Related]
3. In silico and in vitro analysis of PPAR - α / γ dual agonists: Comparative evaluation of potential phytochemicals with anti-obesity drug orlistat. Mandal SK; Kumar BK; Sharma PK; Murugesan S; Deepa PR Comput Biol Med; 2022 Aug; 147():105796. PubMed ID: 35809408 [TBL] [Abstract][Full Text] [Related]
4. Computational analysis of marine algal compounds for obesity management against pancreatic lipase. Prabhakar L; Dicky John DG; Singh SR; Murali A J Biomol Struct Dyn; 2023 Jul; 41(11):4863-4872. PubMed ID: 35575483 [TBL] [Abstract][Full Text] [Related]
5. [Pharmacological therapy of obesity]. Pagotto U; Vanuzzo D; Vicennati V; Pasquali R G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755 [TBL] [Abstract][Full Text] [Related]
6. Kojic acid repurposing as a pancreatic lipase inhibitor and the optimization of its production from a local Aspergillus oryzae soil isolate. El-Korany SM; Helmy OM; El-Halawany AM; Ragab YE; Zedan HH BMC Biotechnol; 2020 Oct; 20(1):52. PubMed ID: 33008398 [TBL] [Abstract][Full Text] [Related]
7. Antiobesity drug-likeness properties and pancreatic lipase inhibition of a novel low molecular weight lutein oxidized product, LOP6. Shamarao N; Chethankumar M Food Funct; 2022 Jun; 13(11):6036-6055. PubMed ID: 35615990 [TBL] [Abstract][Full Text] [Related]
8. Computational study to evaluate the potency of phytochemicals in Sahu SN; Satpathy SS; Mohanty C; Pattanayak SK J Biomol Struct Dyn; 2022 Nov; 40(18):8587-8601. PubMed ID: 33876720 [TBL] [Abstract][Full Text] [Related]
9. Structure-guided Design and Optimization of small Molecules as Pancreatic Lipase Inhibitors using Pharmacophore, 3D-QSAR, Molecular Docking, and Molecular Dynamics Simulation Studies. Modanwal S; Mulpuru V; Mishra N Curr Comput Aided Drug Des; 2023; 19(4):258-277. PubMed ID: 36597611 [TBL] [Abstract][Full Text] [Related]
10. Pancreatic lipase inhibitors: The road voyaged and successes. Kumar A; Chauhan S Life Sci; 2021 Apr; 271():119115. PubMed ID: 33515565 [TBL] [Abstract][Full Text] [Related]
11. Computational approaches for the discovery of natural pancreatic lipase inhibitors as antiobesity agents. Almasri IM Future Med Chem; 2020 Apr; 12(8):741-757. PubMed ID: 32212943 [TBL] [Abstract][Full Text] [Related]
12. Natural inhibitors of pancreatic lipase as new players in obesity treatment. de la Garza AL; Milagro FI; Boque N; Campión J; Martínez JA Planta Med; 2011 May; 77(8):773-85. PubMed ID: 21412692 [TBL] [Abstract][Full Text] [Related]
13. Study of Antiobesity Effect through Inhibition of Pancreatic Lipase Activity of Diospyros kaki Fruit and Citrus unshiu Peel. Kim GN; Shin MR; Shin SH; Lee AR; Lee JY; Seo BI; Kim MY; Kim TH; Noh JS; Rhee MH; Roh SS Biomed Res Int; 2016; 2016():1723042. PubMed ID: 27529064 [TBL] [Abstract][Full Text] [Related]
14. Development of QSAR model using machine learning and molecular docking study of polyphenol derivatives against obesity as pancreatic lipase inhibitor. Modanwal S; Maurya AK; Mishra SK; Mishra N J Biomol Struct Dyn; 2023; 41(14):6569-6580. PubMed ID: 35947118 [TBL] [Abstract][Full Text] [Related]
15. Targeting obesity with plant-derived pancreatic lipase inhibitors: A comprehensive review. Rajan L; Palaniswamy D; Mohankumar SK Pharmacol Res; 2020 May; 155():104681. PubMed ID: 32045666 [TBL] [Abstract][Full Text] [Related]
16. The 2',4',6'-trihydroxyacetophenone isolated from Myrcia multiflora has antiobesity and mixed hypolipidemic effects with the reduction of lipid intestinal absorption. Ferreira EA; Gris EF; Rebello JM; Correia JF; de Oliveira LF; Filho DW; Pedrosa RC Planta Med; 2011 Sep; 77(14):1569-74. PubMed ID: 21472649 [TBL] [Abstract][Full Text] [Related]
17. Anti-Obesity Effect of Arq Zeera and Its Main Components Thymol and Cuminaldehyde in High Fat Diet Induced Obese Rats. Haque MR; Ansari HS Drug Res (Stuttg); 2018 Nov; 68(11):637-647. PubMed ID: 29635674 [TBL] [Abstract][Full Text] [Related]
18. Isolation of new rotenoids from Boerhaavia diffusa and evaluation of their effect on intestinal motility. Borrelli F; Milic N; Ascione V; Capasso R; Izzo AA; Capasso F; Petrucci F; Valente R; Fattorusso E; Taglialatela-Scafati O Planta Med; 2005 Oct; 71(10):928-32. PubMed ID: 16254824 [TBL] [Abstract][Full Text] [Related]
19. Antiobesity potential of ursolic acid stearoyl glucoside by inhibiting pancreatic lipase. Kazmi I; Afzal M; Rahman S; Iqbal M; Imam F; Anwar F Eur J Pharmacol; 2013 Jun; 709(1-3):28-36. PubMed ID: 23500199 [TBL] [Abstract][Full Text] [Related]
20. Drug-guided screening for pancreatic lipase inhibitors in functional foods. Zhang L; Zheng J; Ma M; Zhao Y; Song J; Chen X; Cao W; He X; Xue C; Tang Q Food Funct; 2021 May; 12(10):4644-4653. PubMed ID: 33912875 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]